From Mission to Market Expansion
Eleos began with a clear mission: to free clinicians from paperwork so they could focus on client care. Its Artificial Intelligence (AI) platform listens to care sessions, transcribes them, and generates detailed progress note drafts, reducing documentation time while supporting compliance.
As the company expanded into home health, palliative care, and hospice, the stakes grew higher. These settings carried the same documentation burden as behavioral health, but with added sensitivity and scrutiny. Expansion also meant working more closely with enterprise organizations and regulators who shared a common expectation: innovation had to be matched with assurance that AI systems operate safely and transparently.
Meeting that expectation required more than internal assurances. Healthcare organizations wanted clear evidence of how Eleos managed the risks of predictive AI, documented its decision-making model, and disclosed the sources behind its outputs.
To provide that confidence at scale, Eleos turned to Drummond’s Predictive Decision Support Intervention Risk (pDSI-Risk) Certification, a program modeled on ASTP/ONC’s Health IT federal standards for AI in healthcare, designed to deliver the rigor and credibility that enterprise-size clients demand.
The Certification Journey
The certification process began with a comprehensive review of Eleos’s AI platform and existing policies. Drummond’s role was both advisory and evaluative, helping the team identify where user explanations and disclosures needed to be expanded for AI functionality, and where risk governance practices could be supplemented and documented.
Two priorities emerged early. First was formalizing an Intervention Risk Management summary to document how risks are identified, analyzed, mitigated and governed on an ongoing basis. The second was creating clear Source Attribute documentation for end users. This ensures that whenever the AI provides decision support, clinicians can access explanations about how the model works. These explanations cover areas such as the inputs used, expected outputs, intended uses and populations, potential risks and cautions, validity and bias testing metrics, and additional details on risk management and governance.
By earning Drummond Certified™ status, Eleos gained more than a seal of approval. The certification process helped to standardize their risk and governance documentation and establish clear source-attribute explanations for clinicians.
Governance checkpoints were also built into daily operations, and documentation was completed to address inputs, outputs, intended use, cautions, and bias testing metrics.
This gave Eleos a stronger framework for accountability, positioning them to meet both clinical and regulatory expectations with confidence. At the same time, they established clear health AI compliance disclosures for clinicians, helping users understand and trust how the solution supports their work.
How Certification Transformed Eleos Internally
The result of certification was a more mature Eleos, equipped with the internal confidence and validation that its AI is governed with accountability and rigor. As Drummond’s Senior Director of Advisory Services, Bob Bryan, noted,
“The real value of certification is how it brings clarity to the risk management and governance practices used to manage Health AI, both for the company and its end users. At Eleos, we saw their commitment to showing their best-practice approach to management of their AI solution for health care, with a clear focus on building trust with their user base. That shift, bringing transparency and accountability to the forefront, is exactly what pDSI-Risk was designed to drive.”
That cultural shift was immediately visible inside Eleos. Certification redefined who carries responsibility for AI governance, expanding it beyond engineering to include product, compliance, and leadership. Shared ownership means accountability is no longer confined to a single team but woven into the way the organization operates. Practices that once depended on informal effort, such as documenting risks or reviewing AI updates, were now structured, repeatable, and visible.
The outcome is more than process improvement. Eleos emerged with a stronger foundation for growth, becoming a company where accountability and risk management are not temporary projects but enduring disciplines.
These internal gains did more than strengthen Eleos’ operations; they became the foundation for how the company shows up in the market, shaping conversations with customers, partners, and regulators alike.
The Market Impact of Certification
Since achieving certification, Eleos has seen a noticeable shift in how it engages with customers, partners, and regulators. Instead of walking through lengthy explanations of its internal compliance practices, the team can point to the Drummond Certified™ mark as independent proof of its AI stewardship and accountability. That shorthand removes hesitation from early conversations and immediately establishes credibility.
The certification is now featured in proposals, product materials, and onboarding sessions, making it clear to stakeholders that transparency and oversight are part of Eleos’ DNA.
More importantly, certification has changed the tone of discussions. Rather than digging into whether the technology can be relied upon, conversations increasingly focus on how it can be applied and scaled to deliver value. That shift frees the Eleos team to spend less time explaining the reliability of its systems and more time collaborating with clients on outcomes that matter.
In effect, certification now acts as a trust signal that can accelerate conversations, allowing Eleos to move more quickly from validation to value.
Looking Ahead: Raising the Bar for AI in Healthcare
As Eleos reflects on certification, its leadership ties the achievement back to the company’s broader mission and the people it ultimately serves.
“Post-acute care providers deliver essential support in deeply human moments. They deserve tools that are not only intelligent but also trustworthy. Certification helps us ensure our AI meets that standard, supporting care that is more efficient, compliant, and compassionate,” said Alon Joffe, CEO and Co-founder of Eleos.
That perspective highlights why certification is not the finish line, but a new chapter. Across healthcare, AI is now expected to demonstrate not only innovation, but also accountability.
For Eleos, that means model updates consistently pass through structured review, oversight committees remain active, and clinicians always understand the reasoning behind AI outputs. Over time, these practices transform compliance from a box-checking exercise into part of the organization’s culture.
Eleos’s adoption of Drummond’s pDSI-Risk Certification positions it as both participant and leader in shaping this culture of governed AI. It demonstrates that innovation in behavioral health and post-acute care can coexist with rigorous stewardship. That example sets a blueprint for others: AI tools should arrive with governance built in, not bolted on.
In the end, Eleos’s certification is more than a milestone. It is proof that AI in healthcare can be accountable and effective all at once. The benefits (stronger governance, faster trust with customers, and smoother adoption) are clear. For organizations that have not yet pursued certification, Eleos’ journey makes the case plain. Independent validation is no longer optional. Those who follow this path will be better prepared and ultimately, more competitive in a market where confidence and trust are quickly becoming the deciding factors.